Discover how RAYUS Radiology, a leading national imaging provider, has grown its business over a decade-long partnership with the Radiopharma business of Siemens Healthineers. This growth is driven by their comprehensive PET tracer portfolio and support from industry experts with an average of 20 years' experience.
In today’s complex healthcare environment, reliable and comprehensive imaging services are essential for providers and patients alike. Founded in 1981, RAYUS Radiology pioneered a unique business model, delivering high-quality patient care and treatment options via an outpatient setting. Over the decades, RAYUS expanded its outpatient services to include Hospital Solutions, bringing full-service mobile diagnostic imaging and staffing to hospitals, clinics, and healthcare organizations. RAYUS has grown to include 150 radiology centers and 161 mobile imaging units (CT, MRI, and PET) across 35 states, with Siemens Healthineers serving as the preferred radiopharmacy of 52 of these mobile units. By offering mobile services like PET imaging in rural and urban areas, RAYUS is vital in helping healthcare systems deliver accessible, high-quality advanced imaging to patients nationwide.
“We rely on Siemens Healthineers not only to support our customers but also to keep our internal sales and operations teams informed about current industry developments and upcoming tracers in the pipeline.”
A new partnership
In 2014, RAYUS sought a new PET radiopharmacy provider. Initially hesitant about changing, they ultimately chose Siemens Healthineers, beginning a strong, decade-long partnership. Lori Wright, Vice President of Market Success, is a key team member responsible for selecting vendors. Having evaluated various Fludeoxyglucose F 18 Injection (18F FDG) suppliers, she states, “Siemens Healthineers surpasses all other vendors in delivering FDG, thanks to the comprehensive range of additional services they provide.” In the early years of this partnership, FDG was the primary tracer used for PET imaging, mainly in the oncology space for diagnosing, staging, and restaging various cancers. However, in the past decade, there has been significant innovation in developing novel tracers, resulting in the approval of several FDA-approved tracers targeting specific diseases such as prostate cancer, breast cancer, and Alzheimer’s disease. Staying informed about new radiopharmaceuticals entering the market is essential for imaging centers to remain at the forefront of medical advancements, enhance patient care, and sustain competitive relevance. With its extensive radiology service footprint, RAYUS depends on a reliable radiopharmaceutical provider.
Siemens Healthineers goes beyond supplying radiopharmaceuticals, providing the nation's most expansive PET pharmacy network to ensure broad delivery coverage and scalable solutions that adapt to fluctuating demand. Averaging 20 years of industry experience, the Radiopharma sales team offers expert support and a collaborative approach, tailoring services to the unique needs of diverse markets across the country where RAYUS offers PET/CT imaging.
More than a dose: Siemens Healthineers provides valuable resources
The extensive knowledge of the Radiopharma sales team provides RAYUS with tools to help educate their staff and customers. “We rely on Siemens Healthineers not only to support our customers but also to keep our internal sales and operations teams informed about current industry developments and upcoming tracers in the pipeline. This insight is invaluable in guiding our budget planning and decision-making processes,” stated Wright. RAYUS’ customers who choose Siemens Healthineers as their PET radiopharmaceutical provider have access to an extensive portfolio of marketing materials. Access to these resources assists key decision makers, like account executives and physicians, in remaining informed and maximizing their PET program’s full potential.
The extensive knowledge of the Radiopharma sales team provides RAYUS with tools to help educate their staff and customers. “We rely on Siemens Healthineers not only to support our customers but also to keep our internal sales and operations teams informed about current industry developments and upcoming tracers in the pipeline. This insight is invaluable in guiding our budget planning and decision-making processes,” stated Wright. RAYUS’ customers who choose Siemens Healthineers as their PET radiopharmaceutical provider have access to an extensive portfolio of marketing materials. Access to these resources assists key decision makers, like account executives and physicians, in remaining informed and maximizing their PET program’s full potential.
Establishing a strong business relationship from the outset lays the groundwork for mutual trust, collaboration, and long-term success. "Siemens Healthineers demonstrated this commitment from the very beginning. Angela Murray, Regional Sales Director for the Northeast, established a strong connection with me on day one, aligning with my vision that clinical resources can significantly impact and guide physicians,” Wright explained. She continued, “One of the main initiatives when we entered this contract was to provide account executives with impactful clinical collateral for customers. Simply saying we offer PET/CT as a service wasn’t enough—we needed to guide referring physicians on how to utilize PET to its full potential.” Wright further highlighted PET/CT algorithms as a key resource, illustrating the patient journey and reinforcing the clinical value of PET imaging. “Following the signing of our contract, we collaborated closely with Siemens Healthineers, enabling us to swiftly enhance and optimize our sales collateral; now, ten years later, I estimate 99% of all our marketing collateral has been shaped by what the team has provided,” Wright states.
One of the services offered includes a market analysis to help customers optimize processes, identify new opportunities, and create an effective blueprint for growth. “Before we add a new customer or novel tracer, I reach out to Siemens Healthineers to do a market analysis to see what the potential is and analyze the competitive landscape. This enables us to have transparent, informed discussions with the customer about their projected scan volume, helping us determine whether this is a sound business decision,” Wright stated.
As clinical indications and novel drugs enter the market, navigating complex reimbursement policies becomes increasingly challenging. The Radiopharma sales team addresses these complexities by actively participating in key meetings with RAYUS leadership and delivering crucial updates that influence both RAYUS and their customers. Wright emphasized, "The collaboration with the Radiopharma business of Siemens Healthineers, including Megan Walawender, Director of Sales Training and Programs, and Angela Murray, has been invaluable. Their industry updates and insights into pass-through status and insurance changes have been crucial for our operations and customer relations.” She continues, “Alzheimer’s disease and prostate imaging is a hot topic, and the Radiopharma team is well-informed and equipped to help us address our concerns in real-time.” These expert support actions all impact business growth, “RAYUS has seen nearly 30% increase in PET scan volume over the last four years, thanks to the support and resources provided by Siemens Healthineers.”
“Before we add a new customer or novel tracer, I reach out to Siemens Healthineers to do a market analysis to see what the potential is and analyze the competitive landscape. This enables us to have transparent, informed discussions with the customer about their projected scan volume, helping us determine whether this is a sound business decision.”
Investing in the future
Such incredible growth leaves RAYUS with a different problem: ensuring capacity. Meeting revenue expectations month after month has led leadership to invest more into their infrastructure. “With the support of the Radiopharma team and access to novel tracers, we have seen a significant positive impact on our business growth,” stated Jamie Lodovici, a former account executive at RAYUS, who now serves as a territory manager for the Radiopharma business in the northeast. She emphasized the need for investment in new scanners to meet rising demand. RAYUS has purchased a Siemens Healthineers Biograph Trinion PET-CT* for a mobile unit that will service the southeast region. To further enhance their ability to provide access to underserved and high-demand areas, RAYUS is purchasing eight additional Biograph Trinions in 2025. “It’s not just about increased volume or revenue; we now need to invest more in new scanners to keep up with the demand,” Lodovici stated. Staying informed and up to date with changes in the industry is crucial for every imaging center, and RAYUS is no exception.
Siemens Healthineers offers a variety of tools to help you gain more molecular imaging knowledge and stay updated on current industry topics. Everything PET on the NET (EPOTN), a quarterly newsletter, offers a range of current topics associated with molecular imaging and is used by Wright and her team. “Many of us are signed up for EPOTN; we will then share with others on our team and customers. Megan will also provide updates for our internal newsletter, sharing important details that can directly impact our business,” stated Wright. Another invaluable resource is MI PET Source, Siemens Healthineers' online education hub. This platform offers a wealth of clinical resources, including case studies, whitepapers, webinars with VOICE credit, reimbursement updates, and more—making it a go-to tool for expanding molecular imaging expertise.
"The collaboration with the Radiopharma business of Siemens Healthineers, including Megan Walawender, Director of Sales Training and Programs, and Angela Murray, has been invaluable. Their industry updates and insights into pass-through status and insurance changes have been crucial for our operations and customer relations.”
Long lasting bonds
While a business’s success is critical, the expertise, passion, and dedication of the people behind it truly set it apart. At Siemens Healthineers, employees are not only experts in their respective fields but also deeply committed to understanding and addressing the unique needs of customers. This unwavering dedication and customer-centric approach positions Siemens Healthineers as a trusted leader in the PET radiopharmaceutical industry.
A prime example of this commitment comes from Lodovici, who recalls a time when Walawender went above and beyond to support a critical event. Jamie shared, “I reached out to Megan to see if she could visit the cancer center for me, as I was needed at another site. Without hesitation, she stepped up and offered her time. It’s the little things like this that truly demonstrate the dedication and passion of Siemens Healthineers' employees. They give of themselves—not just for the business, but for the patients we serve.” This selfless dedication is just one example that exemplifies why the Radiopharma business of Siemens Healthineers is more than a PET radiopharmaceutical provider; they are a trusted partner in the healthcare journey, fueling the power of PET to transform patient care and drive medical innovation.
(Left to right) Lori Wright, Vice President of Market Success, Rayus Radiology; followed by Megan Walawender, Director of Sales Training and Programs; Angela Murray, Regional Sales Director, Northeast; and Jamie Lodovici, Territory manager, Northeast—representing the Radiopharma business of Siemens Healthineers
Visit RAYUS Radiology's website to learn more about their PET imaging program
Fludeoxyglucose F 18
Please see Indications and Important Safety Information for Fludeoxyglucose F 18 (18F FDG) Injection.
